Abstract:Objective To explore the thoracic and laparoscopy combined radical operation on esophageal cancer in the elderly and the effect on peripheral blood natural killer cells (NK cell) and T-lymphoid subsets (CD4+, CD8+ and CD4+/CD8+).Method 80 cases of elderly patients with esophageal cancer from January 2017 to January 2019 were selected. Among them, the patients treated with traditional radical esophagectomy from January 2017 to January 2018 as the control group (n = 40), and the patients treated with thoracoscopic combined radical esophagectomy from February 2018 to January 2019 as the observation group (n = 40). The operative indexes, prognosis indexes, the changes of immune indexes (NK cell, CD4+, CD8+ and CD4+/CD8+) before and 7 days after operation, complications after operation, 1-year survival rate after operation, recurrence rate and 36-item short form health survey (SF-36) scale of the two groups were compared.Result The operation time, incision length, extubation time, the pain days and hospitalization time in the observation group were shorter than those in the control group, postoperative thoracic drainage volume and intraoperative bleeding volume less than that in the control group (P < 0.05); The total incidence of postoperative complications in the observation group (12.50%) was lower than that in the control group (35.00%), and the SF-36 scale [(79.37 ± 5.94) vs (72.66 ± 7.78)] was higher than that in the control group, the differences were statistically significant (P < 0.05); The levels of NK cell, CD4+ and CD4+/CD8+ in the two groups were all decreased 7 days after operation (P < 0.05), the levels of NK cell, CD4+ and CD4+/CD8+ in the observation group were higher than those in the control group (P < 0.05); There were no significant difference in the lymph node dissection number, the 1-year survival rate and the recurrence rate between the two groups [(11.67 ± 2.07) vs (11.02 ± 2.15), 82.50% vs 72.50%, 20.00% vs 22.50%) (P > 0.05).Conclusion Thoracic and laparoscopy combined radical operation can effectively protect the immune function of elderly patients with esophageal cancer, reduce postoperative complications, improve the quality of life, and the short-term effect is satisfactory.